Product & Industry News
Page 1 to 16 of 93 |     NEXT PAGE >
ProImmune introduces MutaMap high-throughput service for mutational activity maps of therapeutic proteins
ProImmune, a leader in services for understanding immune responses, today announced the introduction of MutaMap, a new high-throughput assay service for understanding the impact of point mutations on protein therapeutic activity, including monoclonal antibodies.

Read More

Envigo implements first-in-class surgical model tracking system
Groundbreaking software provides real-time tracking, accuracy and data access.

Read More

SYGNIS AG launches TruePrime apoptotic cell free DNA amplification kit for the liquid biopsy market
SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.

Read More

Lonza to Showcase Its Latest Solutions for Enhanced QC Testing and Transfection at SLAS2018
Lonza will be exhibiting at SLAS2018, and will showcase how its automated QC testing solutions and Nucleofector Devices can increase efficiency and throughput in the drug development process. In addition, Lonza is supporting a roundtable discussion on advanced in vitro cancer models for drug discovery and development.

Read More

ADC Bio signs construction agreement with sector specialists WHP
ADC Biotechnology announces the signing of a partnership agreement with multi-disciplined engineering specialists, WHP.

Read More

Plasticell & Anthony Nolan partner in clinical trials of ex vivo expanded cord blood stem cells
Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisation dedicated to saving the lives of people with blood cancers, to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.

Read More

Horizon Discovery introduces Multiplex cfDNA Reference Standard for EGFR mutations to support liquid biopsy assays
Horizon Discovery, a global leader in gene editing and gene modulation technologies, today announces the launch of its new cell line-derived epidermal growth factor receptor (EGFR) Multiplex cell-free DNA (cfDNA) Reference Standard.

Read More

Horizon Release New 5-Fusion Multiplex FFPE RNA Reference Standard
The 5-Fusion Multiplex FFPE RNA Reference Standard from Horizon Discovery is a highly-characterized, biologically-relevant quality control material used to assess the performance of targeted NGS, RT-PCR and RT-qPCR assays aimed at detecting gene fusions.

Read More

Avacta Release New Anti di-Ubiquitin K6 and K33 Affimers
The Anti di-Ubiquitin K6 and K33 Affimers from Avacta are a unique range of binders, with no antibody or aptamer equivalents. The Affimer technology offers a number of essential advantages over other affinity technologies.

Read More

Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor
Cambridge Epigenetix (CEGX), a pioneer in the development and application of epigenetic technologies, today announced the appointment of leading epigenetics-based therapeutics specialist, Professor Mark Dawson to its Scientific Advisory Board (SAB).

Read More

Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant
Sphere Fluidics and Geneva Biotech, have received a €1.6 million grant from Eurostars. The funding will be used to develop large DNA cargo gene delivery and genome engineering systems.

Read More

Symcel secures 3.6 million Euro Horizon 2020 Phase II grant
Symcel, the company behind calScreener, has secured 3.572 million Euro Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.

Read More

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types
Elpis BioMed Ltd has announced today that it has raised funds to bring its human cell products and services to market.

Read More

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K.

Read More

Horizon Discovery's Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation
Horizon Discovery, a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently acquired Dharmacon business. This is the latest addition to the Company’s market-leading Edit-R portfolio for CRISPR-Cas9 genome engineering.

Read More

New treatments to solve global antibiotic crisis could reach the market as early as 2020
Helperby Therapeutics has developed the first sustainable solution to combat all three deadly critical priority pathogens named by World Health Organisation.

Read More

Product & Industry News
Page 1 to 16 of 93 |     NEXT PAGE >